2024 header 1600

Featured

1 Why Encouraging Gender Mutilation is Child Abuse - 18 Exposing WPATH Crimes against children

Article Index

18 Exposing WPATH Crimes against children

On March 5, Mia Hughes published a 241 page report exposing crimes against children committed by the leaders of the World Professional Association for Transgender Health also known as WPATH. This is a group of Trans advocates responsible for the experimental gender mutilation processes that thousands of children in the US are currently being subjected to. You can download the WPATH report at this link:

https://static1.squarespace.com/static/56a45d683b0be33df885def6/t/6602fa875978a01601858171/1711471262073/WPATH+Report+and+Files111.pdf

The evidence in this report comes directly from internal WPATH emails and other internal documents – all of which confirm that WPATH is neither a scientific nor medical organization. The medical abuse of minors, known as “gender-affirming care,” are unethical medical experiments. WPATH leaders advocate for the destruction of healthy reproductive systems, the amputation of healthy breasts, and the surgical removal of healthy genitals as the first and only line of treatment for minors with gender dysphoria.

WPATH go its start in 2007 – immediately appointing themselves as the world’s leading international authority on gender medicine. In 2012, they published Standard of Care (SOC) 7 which recommended experimental puberty blockers and framed being transgender as a normal, healthy, variation of human existence. In 2022, they published SOC 8 which removed almost all lower age requirements. This attack against children led to the formation of an ANTI-WPATH group called Beyond Wpath in 2022. Here is a link to their website: https://beyondwpath.org/

Beyond WPATH has 2755 signers who are all opposed to WPATH. Here is a quote from their website: As mental health professionals, public health scientists, and allied organizations and individuals, we have grave concerns about the damaging physical and mental health impacts of the current Standards of Care released by WPATH (the World Professional Association for Transgender Health). We hold that WPATH has discredited itself. We are signing this Declaration to highlight our grave concerns about WPATH’s Standards of Care, and to encourage parents, schools, psychotherapists, and other health care professionals to utilize the wealth of alternative resources that are now widely available.

The organizations, physicians, research scientists, mental health professionals, and other signatories to this Statement stand together in supporting alternatives to WPATH’s deeply flawed Standards of Care. We align with the most up-to-date science-based guidelines from those countries which have already evaluated and rejected the affirmative approach. We believe health care professionals serving the needs of gender-questioning youth can honor and respect their rights without subscribing to a flawed ideological document marred by ethical failures and factual errors.

We hold that the authoritative status of WPATH’s Standards of Care is fatally undermined by the following errors and ethical failures: The Standards specifically promote the affirmative care model, continuing to endorse widespread medical treatments (drugs and surgery) for trans-identified youth despite rising scientific skepticism that has led Sweden, Finland, France, and the United Kingdom to retreat from that approach. WPATH endorses early medicalization as fundamental while these other countries now promote psychosocial support as the first line of treatment. For these and other reasons, we believe WPATH can no longer be viewed as a trustworthy source of clinical guidance in this field.

The WPATH Files contain abundant evidence that the world-leading transgender health group does not respect the well-established scientific process – as is summarized in the following report:

January 2023 Abbruzzese et al “The Myth of “Reliable Research” in Pediatric Gender Medicine: A Critical Evaluation of the Dutch Studies—and Research That Has Followed.”

https://doi.org/10.1080/0092623x.2022.2150346

The WPATH Files contain abundant evidence demonstrating just how little is known about the puberty blocking and sex hormone drugs and their long-term effects. For example, in the first long term study of minors using puberty suppressors and sex hormones in 2022 found that 27% of the young people who had undergone early puberty suppression followed by sex hormones and surgical removal of the testes or ovaries, at an average age of 32, regretted sacrificing their fertility.

Following systematic reviews of evidence, three European countries—Sweden, Finland and England—have adopted new and much more cautious treatment guidelines for gender dysphoric youth, which prioritize noninvasive psychosocial interventions.

There is no argument that the Dutch experience, and in particular two Dutch studies—de Vries et al. (Citation2011), and de Vries et al. (Citation2014)—forms the foundation of the practice of youth gender transition. It is evident when examining prevailing treatment guidelines.

What the two Dutch studies failed to show, however, is that these physical changes resulted in meaningful psychological improvements significant enough to justify the adverse effects of the treatment—including the certainty of sterility.

Besides the lack of a control group and a small final sample of 55 cases, with key outcomes available for as few as 32 individuals, there are three major areas of concern that render these studies unfit for clinical or policy decision-making.

The Dutch studies did not evaluate physical health outcomes of “gender-affirmative” treatments. Even without setting out to assess the risks, the Dutch research inadvertently revealed that the rate of short-term morbidity and mortality associated with “gender-affirming” interventions is as high as 6%-7%.

The actual outcome is likely to be much worse because the Dutch studies “cherry picked” from an original sample of 196 referred cases by only including the 55 cases with the most desirable outcomes. Even with this, adverse outcomes included severe diabetes, obesity and one death.

Several studies since have confirmed likely adverse health effects of hormonal interventions. Research suggests heightened insulin resistance (Nokoff et al. 2021), elevated blood pressure, elevated triglycerides, and impaired liver function (Olson-Kennedy, Okonta, et al., 2018). Cross-sex hormone administration places adolescents in the medical category of early life indicators of future cardiovascular disease (Jacobs et al., 2022).

At least two studies confirm that psychological interventions absent any medical interventions. are associated with improvements in two of the outcome domains—gender dysphoria (van de Grift et al., 2017) https://pubmed.ncbi.nlm.nih.gov/28319558/

and global function (Costa et al., 2015) https://pubmed.ncbi.nlm.nih.gov/26556015/

Around 2015 the presentation of pediatric gender dysphoria in the Western world sharply shifted, from childhood-onset that skewed toward males, to adolescent-onset with a preponderance of females with mental health problems. Finnish researchers saw a new pattern of “severe psychopathology preceding onset of gender dysphoria,” with 75% already in treatment for other psychiatric issues when their gender dysphoria emerged. Between 2009 and 2016, the number of gender dysphoric females increased more than 70 times. In the US, over 70% of gender dysphoric youth have also been diagnosed with ADHD and other mental health problems before their diagnosis of gender dysphoria (Becerra-Culqui et al., 2018).

Subsequent detransitioner research confirmed that patients reported “that their gender dysphoria began during or after puberty and that mental health issues, trauma, peers, social media, online communities, and difficulty accepting themselves as lesbian, gay, or bisexual were related to their gender dysphoria and desire to transition” (Littman, 2021, p. 15)

The few attempts at long-term follow-up for adults who have undergone sex-trait modification interventions do not show positive outcomes, with individuals showing social difficulties and a significantly elevated rate of completed suicides and mental health issues.

Also, a 2018 study conducted by Kaiser Permanente found that natal males on estrogen had a 5.2% risk of a blood clot in the lungs or legs, a heart attack, or a stroke within 4 years after initiating estrogen (but the increased risk begins as early as one year), and the risks rise the longer a trans-identified natal male takes estrogen. Getahun, D., et al. (2018). Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636681/pdf/nihms-1030323.pdf

Given the lack of scientific literature to indicate that cross-sex hormone therapy is safe and effective, as well as the number of known negative side effects and the possible serious negative outcomes, it is unethical for WPATH to advocate for minors and the severely mentally ill to bypass psychotherapy and have immediate access to these powerful drugs.

The deliberate avoidance of the term “experimental” is due to the fact that experimental medicine is not covered by health insurance, and one of the primary objectives of WPATH’s SOC8 is to secure insurance coverage.

Many detransitioners feel intense anger and grief regarding the irreversible changes wrought by gender-affirming care. They mourn the loss of their body parts and the experiences, such as bearing children or breastfeeding, that have been taken from them.

Changing names and pronouns is often portrayed as a harmless, non-medical step to alleviate a child’s distress. It is sold to parents as completely reversible at any time, but all available evidence suggests the contrary - social transition serves to lock in the transgender identity and leads to puberty blockers. Almost every adolescent who commences puberty blockers proceeded to cross-sex hormones.

Blocking puberty, therefore, means blocking the natural cure to gender dysphoria robbing children of the same developmental process that would almost certainly have enabled them to overcome their dysphoria naturally.

The Transition-or-Suicide Myth makes the false promise that these experimental interventions will eliminate the risk of suicide for the young person when no evidence exists to support such a claim. A Swedish study of 324 individuals who had undergone genital surgery between 1973 and 2003 revealed rates of completed suicide post-surgical transition to be greatly elevated over the general population, with trans-identified natal females 40 times more likely to die by suicide and trans-identified natal males 19 times more likely.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043071/pdf/pone.0016885.pdf